Any negative news regarding current vaccins is an opportunity to promote a "complete" vaccin. A professional PR firm would know how to handle (if) positive progress. Increased doubts of leadership continues, unable to attract interest or meet time-line. The question remains ...... more HOT air or will von Hofe / science team bail out past incompetence????
Altucell , China, Merck/AE37, REVENUE .....UPDATE????
It appears Merck is not interested to support clinical trial financially.......no activity at this time. To complete trial it looks like we are looking at 2024/25 ........ ... if at all......